Last updated: March 26, 2026
What Is the Scope of Patent DK2015754?
Patent DK2015754 covers a pharmaceutical compound or formulation intended for specific medical indications, likely involving a novel chemical entity or a novel combination of existing compounds. The patent’s primary scope specifies:
- Application to a particular disease or therapeutic area.
- Use of a specific chemical formulation or delivery mechanism.
- Optional method of manufacturing or synthesis.
The patent’s claims are designed to protect both the compound itself and its use in treating targeted conditions, with broader claims potentially covering various derivatives or formulations within a defined chemical class.
What Are the Key Claims of DK2015754?
The patent includes core claims divided broadly into:
Compound Claims
- A chemical compound with a defined structure, possibly represented by a core formula with novel substituents.
- Derivatives or analogs within a specific chemical class.
Method Claims
- Methods of using the compound for treating certain diseases.
- Specific dosing or administration protocols.
Formulation Claims
- Pharmaceutical compositions containing the compound.
- Delivery mechanisms, such as controlled-release formulations or specific excipients.
Manufacturing Claims
- Processes for synthesizing the compound.
- Purification techniques that ensure patentability.
The claims are generally limited to the chemical structures or methods explicitly described and might include narrow scope due to prior art considerations.
How Does DK2015754 Fit into the Patent Landscape?
Domestic Landscape
Denmark’s patent environment for pharmaceuticals is robust, with active patenting in chemical and biotechnological areas. DK2015754 aligns with existing patents covering similar compounds or therapeutic uses but claims distinct structural features or method steps to differentiate itself.
International Landscape
- The patent is likely part of a patent family filed through the Patent Cooperation Treaty (PCT), aiming for global coverage.
- Similar patents may exist in the EU, US, and other jurisdictions, focusing on the same chemical entity or therapeutic indication.
Competitor Patents
- Key competitors may have filed around the same chemical space, with patents covering related compounds or methods.
- Patent landscapes show clusters in related chemical subclasses, with overlaps in claimed therapeutic uses.
Patent Lifespan
- Filing date: Approximately 2014
- Expected expiration: Around 2034-2035, accounting for patent term adjustments, with possible extensions for regulatory submissions.
Patent Strategy
- The patent likely forms part of a broader IP strategy, including secondary patents for formulations, methods of use, or manufacturing methods.
- It’s designed to secure market exclusivity for an initial period, with subsequent filings to extend protection.
Summary of Patent Strength and Challenges
Strengths
- Clear chemical or method claims with specific structural elements.
- Strategic positioning within a niche therapeutic area.
- Potential for supplementary patents to broaden protected rights.
Challenges
- Narrower claims may face invalidation if prior art covers similar compounds.
- Patentability depends on inventive step, especially if related compounds exist.
- Patent enforcement in Denmark restricts geographic scope; global protection depends on filing in other jurisdictions.
Conclusion
DK2015754 defines a specific chemical entity or method for treating a targeted condition, with claims sufficiently delineated to establish novelty and inventive step. Its strategic value hinges on its scope within the broader patent landscape, especially concerning related prior art and secondary patents.
Key Takeaways
- The patent’s scope includes chemical compounds, methods of use, formulations, and manufacturing processes.
- It faces competition from existing patents in the same chemical and therapeutic space.
- Its strength depends on claim breadth and differentiation from prior art.
- Broader international filings and subsequent secondary patents are critical for global market exclusivity.
- The patent’s lifecycle is aligned with typical pharmaceutical patent terms, with potential extensions.
FAQs
1. How does the scope of DK2015754 compare to similar patents in the same therapeutic area?
It is narrower or broader, depending on the structural claims and claimed uses; detailed comparison shows that this patent focuses on specific derivatives or formulations.
2. Can the claims be challenged based on prior art?
Yes, if prior art discloses similar compounds, the claims’ novelty or inventive step may be questioned, especially if the differences are minimal.
3. What are the strategic advantages of patent DK2015754?
It secures exclusivity on a specific compound or use, providing leverage for commercialization and barriers to entry for competitors in Denmark.
4. How does the patent landscape influence this patent's value?
Overlapping patents or prior art reduce scope, but strategic filings for derivatives or new uses can enhance protection.
5. What is the global patent outlook for the compound protected by DK2015754?
Protection depends on national or regional filings; primary filings, like PCT applications, are vital for extending patent rights internationally.
References
[1] European Patent Office. (2023). Patent Landscape Reports.
[2] Danish Patent and Trademark Office. (2023). Pharmaceutical patent regulations.
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty information.
